QRP Research TB-500 5mg
 
 
TB-500 is a synthetic peptide associated with the actin-binding region of Thymosin Beta-4 (Tβ4), a naturally occurring peptide involved in cytoskeletal organisation and cellular movement.
TB-500 has attracted scientific interest as an experimental compound for investigating actin-related cellular mechanisms, cell migration, cytoskeletal dynamics and tissue-response pathways.
The relationship between TB-500 and Thymosin Beta-4 is particularly important in research. Full-length Thymosin Beta-4 consists of 43 amino acids and has been extensively investigated in cellular and preclinical models, while TB-500 represents a shorter synthetic peptide associated with its biologically significant actin-related region.
Actin is a fundamental component of the cellular cytoskeleton and plays an essential role in cell shape, movement, division and structural organisation. This relationship has made Thymosin Beta-4-derived peptides an area of interest in research examining cellular migration and tissue remodelling mechanisms.
QRP Research TB-500 5mg is supplied as a lyophilised research peptide intended exclusively for controlled laboratory, analytical and scientific investigation.
Key Research Areas
TB-500 and related Thymosin Beta-4-derived peptides have been investigated experimentally in relation to:
Actin-associated cellular mechanisms
Cytoskeletal organisation and dynamics
Cell migration and motility
Cellular repair-response pathways
Tissue remodelling mechanisms
Extracellular matrix research
Endothelial cell migration
Angiogenesis-related signalling
Inflammatory signalling pathways
Cellular differentiation and survival mechanisms
Peptide-actin interactions
Thymosin Beta-4 structure-function relationships
A particularly important research characteristic of TB-500 is its association with the actin-binding region of Thymosin Beta-4, providing an experimental model for investigating how specific peptide sequences may influence cytoskeletal and cellular processes.
It is important to distinguish research involving TB-500 from research involving full-length Thymosin Beta-4. Findings obtained using the complete parent peptide should not automatically be attributed to the shorter TB-500 research peptide.
Research involving TB-500 remains predominantly laboratory and preclinical, and findings should not be interpreted as evidence of established injury-recovery, tissue-healing, performance-enhancing, therapeutic or other clinical effects in humans.
Product Specification
Compound: TB-500
Related Peptide: Thymosin Beta-4 (Tβ4)
Compound Type: Synthetic Thymosin Beta-4-derived research peptide
Primary Research Area: Actin Biology & Cytoskeletal Signalling
Form: Lyophilised peptide
Quantity: 5mg per vial
Brand: QRP Research
Application: Laboratory and scientific research
Why QRP Research?
QRP Research supplies specialist research materials with an emphasis on quality, consistency and traceability. Products are securely packaged and clearly identified for their intended laboratory application.
Storage
Store in a cool, dry and dark environment, protected from excessive heat, direct light and moisture.
Appropriate laboratory storage procedures should be followed to preserve the stability and integrity of the research material.
Research Use Notice
FOR RESEARCH USE ONLY.
This product is supplied exclusively for laboratory, analytical and scientific research.
NOT for human consumption or administration.
NOT for animal consumption or administration.
NOT a medicine, food supplement or cosmetic product.
NOT intended to diagnose, treat, cure or prevent any disease.
No human dosing or administration instructions are provided.
Intended to be handled only by appropriately qualified researchers or laboratory professionals.
QRP Research TB-500 5mg is supplied strictly as a research material for non-clinical laboratory investigation.